Nico O’Kuinghttons heads the Clinical Research and Real World Evidence business for Tissue Analytics, a Net Health company. He has nearly a decade of experience advancing Real World Data into the wound care research space supporting evidence from Efficacy, Safety and Health Economics & Outcomes Research (HEOR) into the market. Additionally, Mr. O’Kuinghttons has driven the use of a novel mobile imaging solution (Tissue Analytics) into the wound, burn and dermatology research space – spanning deployments in a wide array of clinical trials presently deployed in 38 countries across five continents.
The past year has vividly highlighted the troubling impact the lack of diversity and equity in our nation has on every facet of life. Clinical trials are no exception. Black and Latinx populations constitute about 32% of U.S. residents, but only make up 6 to 8% of all participants in federally-funded clinical trials.1 We’re slowly…
Remember the first time you rode a bike without training wheels? The excitement, fear, anticipation? For a lot of us, those early efforts resulted in a skinned knee or two and perhaps some tears. But within a few days, we were speeding down hills and around corners with the best of them. All it took was a…
Keeping patients engaged and participating You’ve done all the work. You’ve worked with your scientists to develop a product. You have a long-term marketing plan. You’ve prepared a clinical trial protocol to prove the value of your product. Everything is in place, the trial begins. Then, participants start dropping out. “It’s too inconvenient to come…
Industry celebrates clinical trials and its past, present and future on May 20 For many, the unsung heroes of the life-saving drugs and therapies developed over the past century have been the researchers and clinical trial participants who made those innovations possible. That’s one reason why Clinical Trials Day is going to be especially notable…
It’s hard to believe as we reflect over the past year but virtually everything has changed in healthcare. What once was considered leading edge – such as decentralized clinical trials – has started to become the norm. As we slowly move to a “new normal” (whatever that may be), many in the industry are asking…
Will some of the many changes we’ve seen in clinical trials be with us after the pandemic subsides, or will they fade away as we return to what is familiar? There’s a lot to unpack in that one question. However, one trend experts believe will remain for a variety of reasons – including cost, efficiency…
Anyone who has worked in a clinical setting knows that wounds, from burns to ulcers to injuries, are painful, disrupt lives, and often are difficult to treat (needless to say, carry a significant cost burden to our health spend). To find the treatments that will make a difference, small to large medical device manufacturers and…